Vir Biotechnology, Inc. (VIR)
6.54
-0.12
(-1.80%)
USD |
NASDAQ |
Dec 10, 16:00
6.54
0.00 (0.00%)
After-Hours: 18:16
Vir Biotechnology Total Assets (Quarterly): 1.019B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Vistagen Therapeutics, Inc. | 80.93M |
| Bristol Myers Squibb Co. | 96.89B |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
| Theriva Biologics, Inc. | 30.84M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 223.36M |
| Shareholders Equity (Quarterly) | 796.10M |
| Debt to Equity Ratio | 0.1258 |
| Current Ratio | 7.254 |
| Net Debt Paydown Yield | 0.36% |